Increased MYC Gene Copy Number Correlates with Increased MRNA Levels in Diffuse Large B-cell Lymphoma

Overview

Journal Haematologica

Specialty Hematology

Date 2010 Apr 10

PMID 20378577

Citations 33

Authors

Christopher J Stasik

Hiroaki Nitta

Wenjun Zhang

Charles H Mosher

James R Cook

Raymond R Tubbs

Joseph M Unger

Tracy A Brooks

Daniel O Persky

Sarah T Wilkinson

Thomas M Grogan

Lisa M Rimsza

Affiliations

Soon will be listed here.

Abstract

Background: Translocations involving the MYC gene and increased MYC mRNA levels are associated with poor outcome in diffuse large B-cell lymphoma. However, the presence of increased MYC gene copy number and/or polysomy of chromosome 8 have not been previously described.

Design And Methods: Utilizing dual color chromogenic in situ hybridization, we investigated MYC gene copy and chromosome 8 centromere numbers in 52 cases of diffuse large B-cell lymphoma. Cases were divided into those with "increased" or "not increased" MYC gene copy number for comparison with MYC mRNA levels, Ki-67 values, and survival.

Results: Increased MYC gene copy number was present in 38% of cases. Overall, the average MYC mRNA level was 2398 (range, 342 - 9783) and the percentage of nuclei positive for Ki-67 was 57.5% (range, 20-87%). Within the group with increased MYC copy number, the MYC mRNA values ranged from 816 to 5912 (average, 2843) and the Ki-67 values ranged from 23% to 83% (average, 57%). Within the group with not increased MYC copy number, MYC mRNA values ranged from 342 to 9783 (average, 2118) and the Ki-67 values ranged from 20% to 87% (average, 58%). There was a statistically significant relationship between increased MYC gene copy number and increased MYC mRNA (P=0.034) and a trend toward a relationship between increased mRNA and higher Ki-67 values.

Conclusions: This is the first report that low level copy number increases are common in diffuse large B-cell lymphoma and that these changes correlate with MYC mRNA in a statistically significant manner. MYC copy number changes are an additional possible molecular mechanism that may result in increased mRNA and, likely, high proliferation and poor outcome.

Citing Articles

Chromogenic mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS.

Papaleo N, Molina-Alvarez A, Onieva R, Fuertes D, Sanchez-Gonzalez B, Riera X Cancers (Basel). 2024; 16(13).

PMID: 39001439 PMC: 11240605. DOI: 10.3390/cancers16132378.

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B-cell lymphoma patients.

Wang Y, Liu D, Zhang X, Zhang M, Li S, Feng X Cancer Med. 2023; 12(18):18568-18577.

PMID: 37641492 PMC: 10557898. DOI: 10.1002/cam4.6463.

Development of a Prognostic Scoring System using MYC Expression and Soluble Interleukin Receptor -2 level for Diffuse Large B-cell Lymphoma.

Suzuki S, Kuwamoto S, Kawamura K, Matsushita M, Motokura T, Hosoda Y Yonago Acta Med. 2023; 66(1):56-66.

PMID: 36820285 PMC: 9937959. DOI: 10.33160/yam.2023.02.007.

Altered pathways and targeted therapy in double hit lymphoma.

Zhuang Y, Che J, Wu M, Guo Y, Xu Y, Dong X J Hematol Oncol. 2022; 15(1):26.

PMID: 35303910 PMC: 8932183. DOI: 10.1186/s13045-022-01249-9.

Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies.

Salles D, Vidotto T, Faisal F, Tosoian J, Guedes L, Muranyi A J Mol Diagn. 2021; 23(8):1030-1041.

PMID: 34062284 PMC: 8491088. DOI: 10.1016/j.jmoldx.2021.05.006.

References

Simonsson T, Pecinka P, Kubista M . DNA tetraplex formation in the control region of c-myc. Nucleic Acids Res. 1998; 26(5):1167-72. PMC: 147388. DOI: 10.1093/nar/26.5.1167. View

Duncan R, Bazar L, Michelotti G, Tomonaga T, Krutzsch H, Avigan M . A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. Genes Dev. 1994; 8(4):465-80. DOI: 10.1101/gad.8.4.465. View

Pienkowska-Grela B, Witkowska A, Grygalewicz B, Rymkiewicz G, Rygier J, Woroniecka R . Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma. Cancer Genet Cytogenet. 2005; 156(2):114-21. DOI: 10.1016/j.cancergencyto.2004.04.009. View

Kouzine F, Levens D . Supercoil-driven DNA structures regulate genetic transactions. Front Biosci. 2007; 12:4409-23. DOI: 10.2741/2398. View

Wongchaowart N, Kim B, Hsi E, Swerdlow S, Tubbs R, Cook J . t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas. J Cutan Pathol. 2006; 33(4):286-92. DOI: 10.1111/j.0303-6987.2006.00459.x. View

Li C, Kim S, Rai D, Bolla A, Adhvaryu S, Kinney M . Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood. 2009; 113(26):6681-90. PMC: 3401058. DOI: 10.1182/blood-2009-01-202028. View

Michelotti G, Michelotti E, Pullner A, Duncan R, Eick D, Levens D . Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol Cell Biol. 1996; 16(6):2656-69. PMC: 231256. DOI: 10.1128/MCB.16.6.2656. View

ODonnell K, Wentzel E, Zeller K, Dang C, Mendell J . c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435(7043):839-43. DOI: 10.1038/nature03677. View

Shipp M, Ross K, Tamayo P, Weng A, Kutok J, Aguiar R . Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002; 8(1):68-74. DOI: 10.1038/nm0102-68. View

10.

Tome M, Johnson D, Rimsza L, Roberts R, Grogan T, Miller T . A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood. 2005; 106(10):3594-601. PMC: 1895056. DOI: 10.1182/blood-2005-02-0487. View

11.

Marcu K, Patel A, Yang Y . Differential regulation of the c-MYC P1 and P2 promoters in the absence of functional tumor suppressors: implications for mechanisms of deregulated MYC transcription. Curr Top Microbiol Immunol. 1997; 224:47-56. DOI: 10.1007/978-3-642-60801-8_4. View

12.

Pullner A, Mautner J, Albert T, Eick D . Nucleosomal structure of active and inactive c-myc genes. J Biol Chem. 1996; 271(49):31452-7. DOI: 10.1074/jbc.271.49.31452. View

13.

Kantarjian H, Walters R, Keating M, Smith T, OBrien S, Estey E . Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol. 1990; 8(6):994-1004. DOI: 10.1200/JCO.1990.8.6.994. View

14.

Fernandez P, Frank S, Wang L, Schroeder M, Liu S, Greene J . Genomic targets of the human c-Myc protein. Genes Dev. 2003; 17(9):1115-29. PMC: 196049. DOI: 10.1101/gad.1067003. View

15.

Kouzine F, Sanford S, Elisha-Feil Z, Levens D . The functional response of upstream DNA to dynamic supercoiling in vivo. Nat Struct Mol Biol. 2008; 15(2):146-54. DOI: 10.1038/nsmb.1372. View

16.

Rosenwald A, Wright G, Chan W, Connors J, Campo E, Fisher R . The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346(25):1937-47. DOI: 10.1056/NEJMoa012914. View

17.

Rimsza L, LeBlanc M, Unger J, Miller T, Grogan T, Persky D . Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2008; 112(8):3425-33. PMC: 4467875. DOI: 10.1182/blood-2008-02-137372. View

18.

Au W, Horsman D, Gascoyne R, Viswanatha D, Klasa R, Connors J . The spectrum of lymphoma with 8q24 aberrations: a clinical, pathological and cytogenetic study of 87 consecutive cases. Leuk Lymphoma. 2004; 45(3):519-28. DOI: 10.1080/10428190310001593120. View

19.

Hurley L, Von Hoff D, Siddiqui-Jain A, Yang D . Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element. Semin Oncol. 2006; 33(4):498-512. DOI: 10.1053/j.seminoncol.2006.04.012. View

20.

Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo R, Croce C . Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982; 79(24):7824-7. PMC: 347441. DOI: 10.1073/pnas.79.24.7824. View